ASPEN PHARMACARE HOLDINGS LIMITED - Completion of United Kingdom Competition Authority Investigation
Completion of United Kingdom Competition Authority Investigation
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively “Aspen” or “the Group”)
COMPLETION OF UNITED KINGDOM (“UK”) COMPETITION AUTHORITY INVESTIGATION
Shareholders are advised that the Competition and Markets Authority of the UK has confirmed its decision
to impose a fine of £2,101,954 on Aspen, as reported by Aspen in its SENS Announcement of 14 August
2019 (available on the Aspen website (www.aspenpharma.com) at the Investor Relations section). This
brings this matter to a close.
Durban
09 July 2020
Sponsor
Investec Bank Limited
Date: 09-07-2020 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
